GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $409,000 | +87.6% | 6,016 | -4.8% | 0.23% | +260.0% |
| Q1 2022 | $218,000 | -28.3% | 6,321 | -39.3% | 0.06% | -19.8% |
| Q4 2021 | $304,000 | -5.9% | 10,418 | -17.9% | 0.08% | +14.1% |
| Q3 2021 | $323,000 | +47.5% | 12,696 | +108.6% | 0.07% | +69.0% |
| Q2 2021 | $219,000 | -13.1% | 6,086 | -1.6% | 0.04% | -14.3% |
| Q1 2021 | $252,000 | -7.4% | 6,188 | -1.6% | 0.05% | 0.0% |
| Q4 2020 | $272,000 | -13.4% | 6,288 | +10.4% | 0.05% | -23.4% |
| Q3 2020 | $314,000 | -8.5% | 5,695 | +4.9% | 0.06% | -14.7% |
| Q2 2020 | $343,000 | +23.4% | 5,430 | -0.1% | 0.08% | +8.7% |
| Q1 2020 | $278,000 | +16.3% | 5,435 | +80.8% | 0.07% | +43.8% |
| Q4 2019 | $239,000 | – | 3,006 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |